Current federal disruptions to research funding are survivable — for now. But Diermeier is clear: America cannot remain a scientific superpower without sustained funding and the ability to attract global talent. The window to fix this is not infinite.
Where this was said
At 52:30 · chapter starts 48:55
Dubner challenges Diermeier on the innovation narrative, noting that top researchers are being poached by private sector hyperscalers and that foreign researchers are increasingly reluctant to come to or remain in the US. Diermeier pushes back on anecdote-driven alarm while acknowledging the structural concerns. The private-sector recruitment of AI researchers is not unprecedented — it mirrors earlier talent flows around the birth of Google and auction theory — and tends to ebb and flow. The harder question is whether a sustained funding and political environment could trigger a genuine brain drain. Diermeier's verdict: right now it's a flesh wound [1] — Daniel Diermeier "My sense is, is that it's a bit of a flesh wound right now. If it continues for longer, that would really be destructive because we cannot …" 53:15 . But he reaches for a historical parallel that is genuinely alarming: the University of Berlin, once home to a quarter of all Nobel laureates, was destroyed by the Nazis, creating the scientific diaspora that built American science — from the Manhattan Project to the birth of computing. America's scientific dominance is a product of being a talent magnet. Losing that status would be civilizationally significant.
The University of Berlin had a quarter of all Nobel laureates at its peak. The Nazis destroyed it, creating the exodus of Einstein, von Neumann, and Fermi to the US. America's scientific dominance was built on that diaspora — and it could be lost.
At its peak, the University of Berlin produced approximately one-fourth of all Nobel laureates before its destruction under the Nazis.
Social norms compress behavior so effectively that we assume other minds are similar to ours. They almost never are. After running over 100 psychology studies, Greenberg's biggest finding is that humans are far more different from each other than we intuitively believe.
The widely shared claim that we have a credit card's worth of plastic in our brains may be a massive overestimate. Researchers used nitrile gloves to measure microplastics — and nitrile gloves shed microplastic particles onto the measuring device. A second paper found the original tool used was unreliable, and that we may have far less plastic than reported.
RSD isn't just hurt feelings — it's a dopamine-deficient brain with a hyperactive amygdala and a frayed connection to the prefrontal cortex. Add a surge of norepinephrine and you get chest pain, sweating, and trembling that convinces your body something catastrophic is happening.
In Dan Ariely's door experiment, participants sacrificed the highest-reward door — repeatedly — just to avoid seeing other doors disappear. Even when researchers trained them to use the best door, they kept wasting clicks to maintain options. This is the bias that runs our lives: we'll take a worse outcome to preserve the feeling of optionality.
Dan Gilbert discovered that the brain has a 'psychological immune system' — it misremembers, reframes, and rationalizes to keep you satisfied with whatever you chose. The fear before commitment is all about potential regret. But after committing, your brain quietly starts justifying the choice — and the more irreversible the decision, the stronger the effect.
The psychological immune system can get you through the first few months of any commitment. But durable, long-term well-being requires self-concordance — choosing commitments that are genuinely aligned with your values and what you actually want. Without that alignment, the satisfaction fades fast.
Vision didn't just help animals find food — it ignited the Cambrian explosion of speciation. Half of the human cortex is devoted to visual processing, and that same visual hierarchy directly inspired the neural network architectures powering today's AI.
Peptides come loaded with a powerful narrative: regenerative, subcutaneous, targeted, cutting-edge. That narrative can genuinely move outcomes, especially for pain, energy, and recovery. The RCT's job is to quantify how much additional benefit comes from the molecule itself — above and beyond the compelling story surrounding it.
A pharmaceutical is not an amino acid sequence — it is the successful solution to manufacturing, purification, formulation, and consistency challenges. When clinical trials prove a drug works, they validate a specific product under specific processes, not every preparation that shares the same sequence.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.